These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 4723698)
1. The treatment of cerebrovascular disease with clofibrate. Final report of the Veterans Administration Cooperative Study of Atherosclerosis, Neurology Section. Stroke; 1973; 4(4):684-93. PubMed ID: 4723698 [No Abstract] [Full Text] [Related]
2. Estrogenic therapy in men with ischemic cerebrovascular disease: effect on recurrent cerebral infarction and survival. Final report of the Veterans Administration cooperative study of atherosclerosis, neurology section. Stroke; 1972; 3(4):427-33. PubMed ID: 4340244 [No Abstract] [Full Text] [Related]
3. [Statistics for the study of cerebrovascular insufficiency due to occlusive or stenotic lesions of the carotid artery. I]. Tedeschi G; Signorelli CD; De Divitiis E Rass Int Clin Ter; 1971 May; 51(9):534-42. PubMed ID: 5088698 [No Abstract] [Full Text] [Related]
4. Clofibrate in coronary heart disease. Effect on morbidity and mortality. Krasno LR; Kidera GJ JAMA; 1972 Feb; 219(7):845-51. PubMed ID: 5066667 [No Abstract] [Full Text] [Related]
5. Clofibrate and niacin in coronary heart disease. JAMA; 1975 Jan; 231(4):360-81. PubMed ID: 1088963 [No Abstract] [Full Text] [Related]
6. Ischaemic heart disease: a secondary prevention trial using clofibrate. Report by a research committee of the Scottish Society of Physicians. Research Committee of the Scottish Society of Physicians Br Med J; 1971 Dec; 4(5790):775-84. PubMed ID: 4943606 [TBL] [Abstract][Full Text] [Related]
7. Trial of clofibrate in the treatment of ischaemic heart disease. Five-year study by a group of physicians of the Newcastle upon Tyne region. Br Med J; 1971 Dec; 4(5790):767-75. PubMed ID: 4943605 [TBL] [Abstract][Full Text] [Related]
8. Impotence in patients treated with clofibrate. Schneider J; Kaffarnik H Atherosclerosis; 1975; 21(3):455-7. PubMed ID: 50074 [TBL] [Abstract][Full Text] [Related]
9. Clofibrate for prevention of myocardial infarction. Med Lett Drugs Ther; 1973 Apr; 15(9):37-8. PubMed ID: 4704699 [No Abstract] [Full Text] [Related]
10. Secondary prevention trials using clofibrate: a joint commentary on the Newcastle and Scottish trials. Dewar HA; Oliver MF Br Med J; 1971 Dec; 4(5790):784-6. PubMed ID: 4943607 [No Abstract] [Full Text] [Related]
11. Cholesterol, coronaries, clofibrate and death. Oliver MF N Engl J Med; 1978 Dec; 299(24):1360-2. PubMed ID: 362204 [No Abstract] [Full Text] [Related]
12. [Apoplectic stroke as an event in the course of cerebral arteriosclerosis]. Erbslöh F; Rompel K Med Klin; 1969 Nov; 64(45):2059-67. PubMed ID: 5385984 [No Abstract] [Full Text] [Related]
15. An evaluation of estrogenic substances in the treatment of cerebral vascular disease. Report of the Veterans Administration Cooperative Study of Atherosclerosis, Neurology Section. Circulation; 1966 May; 33(5 Suppl):II3-9. PubMed ID: 4378175 [No Abstract] [Full Text] [Related]
16. Effect of clofibrate on progression of coronary disease: a prospective angiographic study in man. Cohn K; Sakai FJ; Langston MF Am Heart J; 1975 May; 89(5):591-8. PubMed ID: 1091127 [TBL] [Abstract][Full Text] [Related]
17. Editorial: After a coronary. Br Med J; 1975 Apr; 2(5963):103-5. PubMed ID: 1125693 [No Abstract] [Full Text] [Related]
18. Clofibrate for the treatment of occlusive cerebrovascular disease. Hirsch SB; Wechsler AF; Tourtellotte WW N Engl J Med; 1972 Sep; 287(13):671. PubMed ID: 4561834 [No Abstract] [Full Text] [Related]
19. General therapeutic and prophylactic problems in the treatment of atherosclerosis. Begg TB Acta Cardiol; 1972; ():Suppl 15:101-1. PubMed ID: 4583031 [No Abstract] [Full Text] [Related]